Proliferating cells, in particular tumor cells, express a dimeric isoenzyme of pyruvate kinase, termed Tumor M2 pyruvate kinase. In the last few years, much attention has been paid to this novel ...

CLDN18 is specifically expressed in the stomach and lungs. Among the two isoforms of CLDN18 produced through alternative splicing, CLDN18.2 serves as a highly selective marker for gastric lineage ...

Among patients with resected gallbladder cancer, the addition of chemoradiation to chemotherapy treatment did not improve ...

Identification of genes inactivated by promoter CpG methylation is a powerful approach to discover novel tumor suppressor candidates. PCDH10suppresses gastric cancer cell growth through cell ...

More information: Liwei An et al, Road of no return—loss of TP53 paves a defined evolution path from gastric ...

Epidermal growth factor receptor (EGFR) is a major driver of cancer dissemination and target for anti-cancer therapies but ...

Gastric cancer diagnostics companies are Abbott, BD, Bio-Rad Laboratories, Roche, Siemens Healthineers, Thermo Fisher Scientific, Pillar Biosciences, ETC ...

Xilio Therapeutics (XLO) announced initial data from its ongoing Phase 2 clinical trial evaluating vilastobart, or XTX101, a tumor-activated, ...